Not independent
Tenure on this board
1.5 yrs
Also a director at
Bioventus Inc (BVS)
Meeting calendar
CNMD · Annual meeting · Monday, May 18, 2026
Conmed Corp
7 nominees · 3 ballot items.
Election of seven directors; advisory vote to approve Named Executive Officer compensation (Say on Pay); and ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026.
Market cap
$1.3B
1Y TSR
-28.3%
Board grade
C-
Record date
Mar 24, 2026
Filing
DEF 14A
Meeting concluded · May 18, 2026
Follow how the vote landed and what changed on Conmed Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect seven nominees to the Board of Directors for one-year terms.
- 2
Say on Pay
ManagementBoard: FORAdvisory (non-binding) vote to approve the compensation of the Company’s Named Executive Officers as disclosed in the proxy statement.
More detail
The proposal seeks a non-binding advisory approval of the Company’s executive compensation disclosure, asking shareholders to endorse the compensation paid to Named Executive Officers as presented in the CD&A and related tables. Management argues the program aligns pay with performance via performance-based bonuses tied to Net Sales (FX Adjusted), Adjusted EPS and Operating Cash Flow, and long-term equity incentives (stock options and PSUs tied to three-year rTSR). The Board recommends a “FOR” vote, citing the Compensation Committee’s review, stockholder support in prior say-on-pay votes (≈97% in 2025), and governance features such as clawback policy, stock ownership guidelines, prohibition on hedging/pledging, and consultant oversight that mitigate excessive risk. The vote is advisory and non-binding, but the Board will consider results when setting future compensation.
- 3
Ratification of Appointment of PricewaterhouseCoopers LLP for 2026
ManagementBoard: FORRatify PwC as the Company’s independent registered public accounting firm for 2026.
Director elections
Nominees on the ballot7
Independent
Tenure on this board
11.1 yrs
Independent
Tenure on this board
6.8 yrs
Also a director at
Concentrix Corp (CNXC)
Independent
Tenure on this board
12.0 yrs
Independent
Tenure on this board
1.4 yrs
Independent
Tenure on this board
0.9 yrs
Also a director at
Bio-techne Corp (TECH)
Independent
Tenure on this board
6.8 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 11.4% | 3,444,887 | $122M |
| 2 | EARNEST PARTNERS LLC | 8.5% | 2,569,653 | $91M |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.9% | 2,076,417 | $73M |
| 4 | FULLER THALER ASSET MANAGEMENT, INC. | 5.5% | 1,641,766 | $58M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.6% | 1,384,042 | $49M |
| 6 | STATE STREET CORP | 4.6% | 1,384,018 | $49M |
| 7 | DIMENSIONAL FUND ADVISORS LP | 4.4% | 1,327,766 | $47M |
| 8 | BANK OF AMERICA CORP /DE/ | 3.4% | 1,033,906 | $37M |
| 9 | SEI INVESTMENTS CO | 3.3% | 1,003,814 | $35M |
| 10 | COOKE BIELER LP | 3.3% | 987,783 | $35M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Conmed Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Avanos Medical IncAVNS
Special meeting·Jul 22, 2026·$1.2B
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$1.7B
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.7B
Aura Biosciences IncAURA
Special meeting·Aug 5, 2026·$723M
Indaptus Therapeutics IncINDP
Annual meeting·Aug 10, 2026·$287M
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.4B
Reference
Frequently asked questions
- When is the Conmed Corp 2026 annual meeting?
- Conmed Corp (CNMD) holds its 2026 annual shareholder meeting on Monday, May 18, 2026.
- What is the record date for the Conmed Corp 2026 meeting?
- The record date for the Conmed Corp 2026 meeting is Tuesday, March 24, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Conmed Corp's 2026 meeting?
- The board is presenting 7 director nominees at the Conmed Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Conmed Corp 2026 meeting?
- Shareholders will vote on 3 proposals at the Conmed Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.